Wenning Qin, Director of Genome Engineering at eGenesis.
Wenning earned a Ph.D. in pharmacology from Southern Illinois University and completed a postdoctoral training in molecular biology from Washington University in St. Louis, School of Medicine. In her professional career, she has been focusing on design and creation of genetically engineered mouse models, and her association includes Monsanto Life Sciences, Pharmacia Corporation, Pfizer Inc., the Jackson Laboratory, and Biogen. She is currently director of Genome Engineering with eGenesis, managing the design and creation of genetically engineered pig models for the purpose of xenotransplantation.